BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 25008569)

  • 1. MiR-141 targets ZEB2 to suppress HCC progression.
    Wu SM; Ai HW; Zhang DY; Han XQ; Pan Q; Luo FL; Zhang XL
    Tumour Biol; 2014 Oct; 35(10):9993-7. PubMed ID: 25008569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miR-154 targeting ZEB2 in hepatocellular carcinoma functions as a potential tumor suppressor.
    Pang X; Huang K; Zhang Q; Zhang Y; Niu J
    Oncol Rep; 2015 Dec; 34(6):3272-9. PubMed ID: 26503460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR-139-5p inhibits epithelial-mesenchymal transition, migration and invasion of hepatocellular carcinoma cells by targeting ZEB1 and ZEB2.
    Qiu G; Lin Y; Zhang H; Wu D
    Biochem Biophys Res Commun; 2015 Jul; 463(3):315-21. PubMed ID: 26022123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p53 regulates epithelial-mesenchymal transition through microRNAs targeting ZEB1 and ZEB2.
    Kim T; Veronese A; Pichiorri F; Lee TJ; Jeon YJ; Volinia S; Pineau P; Marchio A; Palatini J; Suh SS; Alder H; Liu CG; Dejean A; Croce CM
    J Exp Med; 2011 May; 208(5):875-83. PubMed ID: 21518799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulatory role of miR-211-5p in hepatocellular carcinoma metastasis by targeting ZEB2.
    Jiang G; Wen L; Deng W; Jian Z; Zheng H
    Biomed Pharmacother; 2017 Jun; 90():806-812. PubMed ID: 28437884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive profiling of novel microRNA-9 targets and a tumor suppressor role of microRNA-9 via targeting IGF2BP1 in hepatocellular carcinoma.
    Zhang J; Cheng J; Zeng Z; Wang Y; Li X; Xie Q; Jia J; Yan Y; Guo Z; Gao J; Yao M; Chen X; Lu F
    Oncotarget; 2015 Dec; 6(39):42040-52. PubMed ID: 26547929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-200a suppresses metastatic potential of side population cells in human hepatocellular carcinoma by decreasing ZEB2.
    Yang X; Wang J; Qu S; Zhang H; Ruan B; Gao Y; Ma B; Wang X; Wu N; Li X; Dou K; Li H
    Oncotarget; 2015 Apr; 6(10):7918-29. PubMed ID: 25797260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MiR-132 suppresses the migration and invasion of lung cancer cells via targeting the EMT regulator ZEB2.
    You J; Li Y; Fang N; Liu B; Zu L; Chang R; Li X; Zhou Q
    PLoS One; 2014; 9(3):e91827. PubMed ID: 24626466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Forkhead box Q1 promotes hepatocellular carcinoma metastasis by transactivating ZEB2 and VersicanV1 expression.
    Xia L; Huang W; Tian D; Zhang L; Qi X; Chen Z; Shang X; Nie Y; Wu K
    Hepatology; 2014 Mar; 59(3):958-73. PubMed ID: 24005989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LncRNA SNHG3 Promotes Hepatocellular Tumorigenesis by Targeting miR-326.
    Zhao Q; Wu C; Wang J; Li X; Fan Y; Gao S; Wang K
    Tohoku J Exp Med; 2019 Sep; 249(1):43-56. PubMed ID: 31548493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LncRNA SNHG15 promotes hepatocellular carcinoma progression by sponging miR-141-3p.
    Ye J; Tan L; Fu Y; Xu H; Wen L; Deng Y; Liu K
    J Cell Biochem; 2019 Dec; 120(12):19775-19783. PubMed ID: 31310393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MiR-221 Promotes Hepatocellular Carcinoma Cells Migration via Targeting PHF2.
    Fu Y; Liu M; Li F; Qian L; Zhang P; Lv F; Cheng W; Hou R
    Biomed Res Int; 2019; 2019():4371405. PubMed ID: 31214616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-144 suppresses the proliferation and metastasis of hepatocellular carcinoma by targeting E2F3.
    Cao T; Li H; Hu Y; Ma D; Cai X
    Tumour Biol; 2014 Nov; 35(11):10759-64. PubMed ID: 25073510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MiRNA-1179 suppresses the metastasis of hepatocellular carcinoma by interacting with ZEB2.
    Gao HB; Gao FZ; Chen XF
    Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5149-5157. PubMed ID: 31298368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel ETV6-miR-429-CRKL regulatory circuitry contributes to aggressiveness of hepatocellular carcinoma.
    Guo C; Gao C; Zhao D; Li J; Wang J; Sun X; Liu Q; Hao L; Greenaway FT; Tian Y; Liu S; Sun MZ
    J Exp Clin Cancer Res; 2020 Apr; 39(1):70. PubMed ID: 32326970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-188-5p suppresses tumor cell proliferation and metastasis by directly targeting FGF5 in hepatocellular carcinoma.
    Fang F; Chang RM; Yu L; Lei X; Xiao S; Yang H; Yang LY
    J Hepatol; 2015 Oct; 63(4):874-85. PubMed ID: 25998163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-608 acts as a prognostic marker and inhibits the cell proliferation in hepatocellular carcinoma by macrophage migration inhibitory factor.
    Wang K; Liang Q; Wei L; Zhang W; Zhu P
    Tumour Biol; 2016 Mar; 37(3):3823-30. PubMed ID: 26474589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-335 inhibits invasion and metastasis of colorectal cancer by targeting ZEB2.
    Sun Z; Zhang Z; Liu Z; Qiu B; Liu K; Dong G
    Med Oncol; 2014 Jun; 31(6):982. PubMed ID: 24829139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-185 inhibits hepatocellular carcinoma growth by targeting the DNMT1/PTEN/Akt pathway.
    Qadir XV; Han C; Lu D; Zhang J; Wu T
    Am J Pathol; 2014 Aug; 184(8):2355-64. PubMed ID: 24911372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-338-3p inhibits cell proliferation in hepatocellular carcinoma by target forkhead box P4 (FOXP4).
    Wang G; Sun Y; He Y; Ji C; Hu B; Sun Y
    Int J Clin Exp Pathol; 2015; 8(1):337-44. PubMed ID: 25755720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.